2012
ANALYSIS OF SELECTED REGULATORY GENES IN PROSTATE CANCER CELL LINES
SZTALMACHOVÁ, Markéta; Marián HLAVNA; Jaromír GUMULEC; Monika HOLUBOVÁ; Petr BABULA et al.Základní údaje
Originální název
ANALYSIS OF SELECTED REGULATORY GENES IN PROSTATE CANCER CELL LINES
Autoři
SZTALMACHOVÁ, Markéta; Marián HLAVNA; Jaromír GUMULEC; Monika HOLUBOVÁ ORCID; Petr BABULA; Jan BALVAN; Martina RAUDENSKÁ ORCID; Veronika TANHÄUSEROVÁ; Vojtěch ADAM; René KIZEK a Michal MASAŘÍK
Vydání
12th Workshop of Physical Chemists and Electrochemists, 2012
Další údaje
Jazyk
angličtina
Typ výsledku
Konferenční abstrakt
Obor
Genetika a molekulární biologie
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 3.729 v roce 2011
Označené pro přenos do RIV
Ne
ISBN
978-80-7375-618-5
ISSN
Klíčová slova anglicky
prostate cell lines; prostate cancer; Bcl-2; c-Fos; c-Jun; Ki-67; NF-kB; p53; qRT-PCR
Změněno: 24. 10. 2012 11:58, Mgr. Martina Raudenská, Ph.D.
Anotace
V originále
In this study, we aimed our attention on determining of expression of Bcl-2, c-Fos, c-Jun, Ki-67, NF-kB and p53 genes in two prostate cell lines as 22Rv1 cell line, a model of aggressive partially androgen-sensitive prostate cancer and as PNT1A cell line, a model of healthy cell line. 22Rv1 cells demonstrate different expression patterns in monitored genes compared to PNT1A cells. 22Rv1 cell line has 4.5-fold higher level of Bcl-2 anti-apoptotic gene expression (n = 5). Interestingly, we found no significant differences in c-Jun gene expression in both cell lines. c-Fos gene that together with c-Jun forms important part of AP-1 transcription factor shows 2.5-fold down regulation in 22Rv1 cells. Ki-67, a nuclear protein that is associated with cellular proliferation, is present in 22Rv1 cell line in 2-fold higher concentration compared to PNT1A. Moreover, NF-kB is present in half concentration in 22Rv1cells compared to PNT1A and p53, a key regulator of apoptosis, shows 3.3-fold decreased level compared with PNT1A cell line.